Integra LifeSciences Holdings Corporation (NASDAQ: IART) is -30.18% lower on its value in year-to-date trading and has touched a low of $39.78 and a high of $62.99 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IART stock was last observed hovering at around $40.48 in the last trading session, with the day’s loss setting it -1.33% off its average median price target of $53.50 for the next 12 months. It is also 39.77% off the consensus price target high of $65.00 offered by 14 analysts, but current levels are -0.38% lower than the price target low of $39.00 for the same period.
Currently trading at $39.15, the stock is -22.68% and -27.70% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.89 million and changing -3.29% at the moment leaves the stock -25.83% off its SMA200. IART registered -35.49% loss for a year compared to 6-month gain of -25.49%. The firm has a 50-day simple moving average (SMA 50) of $3.58 and a 200-day simple moving average (SMA200) of $20.93.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
The stock witnessed a -33.46% loss in the last 1 month and extending the period to 3 months gives it a -31.10%, and is -21.18% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.44% over the week and 3.32% over the month.
Integra LifeSciences Holdings Corporation (IART) has around 3722 employees, a market worth around $3.20B and $1.56B in sales. Current P/E ratio is 18.96 and Fwd P/E is 10.28. Profit margin for the company is 11.00%. Distance from 52-week low is -1.58% and -37.85% from its 52-week high. The company has generated returns on investments over the last 12 months (6.20%).
Integra LifeSciences Holdings Corporation (IART) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Integra LifeSciences Holdings Corporation (IART) is a “Hold”. 14 analysts offering their recommendations for the stock have an average rating of 2.80, where 7 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 2 analysts have rated the stock as a Sell or Underperform.
Integra LifeSciences Holdings Corporation is expected to release its quarterly report on 07/26/2023.The EPS is expected to grow by 9.30% this year
Integra LifeSciences Holdings Corporation (IART) Top Institutional Holders
The shares outstanding are 81.87M, and float is at 72.65M with Short Float at 5.07%.
Integra LifeSciences Holdings Corporation (IART) Insider Activity
A total of 72 insider transactions have happened at Integra LifeSciences Holdings Corporation (IART) in the last six months, with sales accounting for 42 and purchases happening 30 times. The most recent transaction is an insider sale by McBreen Michael J., the company’s EVP & President, CSS. SEC filings show that McBreen Michael J. sold 1,843 shares of the company’s common stock on Mar 07 at a price of $54.29 per share for a total of $0.1 million. Following the sale, the insider now owns 28796.0 shares.
Integra LifeSciences Holdings Corporation disclosed in a document filed with the SEC on Mar 01 that DAVIS ROBERT T. JR. (EVP & President, TT) sold a total of 1,566 shares of the company’s common stock. The trade occurred on Mar 01 and was made at $55.21 per share for $86463.0. Following the transaction, the insider now directly holds 45920.0 shares of the IART stock.
Still, SEC filings show that on Feb 27, Evoli Lisa (EVP & CHRO) disposed off 3,767 shares at an average price of $57.00 for $0.21 million. The insider now directly holds 18,605 shares of Integra LifeSciences Holdings Corporation (IART).
Integra LifeSciences Holdings Corporation (IART): Who are the competitors?
The company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading -12.70% down over the past 12 months and DENTSPLY SIRONA Inc. (XRAY) that is -3.56% lower over the same period. Zimmer Biomet Holdings Inc. (ZBH) is 6.45% up on the 1-year trading charts.